Catecholaminergic depletion within the prelimbic medial prefrontal cortex enhances latent inhibition

Neuroscience

Volumn 170, Issue 1, 2010, Pages 99-106

  Nelson, A J D ^a   Thur, K E ^a   Marsden, C A ^a   Cassaday, H J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Dopamine; Infralimbic cortex; Latent inhibition; Prelimbic cortex; Schizophrenia

Indexed keywords

DOPAMINE; OXIDOPAMINE;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINERGIC SYSTEM; CONDITIONING; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; EMOTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LATENT INHIBITION; MALE; MOTIVATION; NOISE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; THIRST;

ANIMALS; CATECHOLAMINES; INHIBITION (PSYCHOLOGY); LIMBIC SYSTEM; MALE; PREFRONTAL CORTEX; RANDOM ALLOCATION; RATS; RATS, WISTAR; REACTION TIME; TIME FACTORS;

EID: 77955922388     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.066     Document Type: Article

References (55)

1. Aggleton J.P., Neave N., Nagle S., Sahgal A. A comparison of the effects of medial prefrontal, cingulated cortex, and cingulum bundle lesions on tests of spatial memory: evidence of a double dissociation between frontal and cingulum bundle contributions. J Neurosci 1995, 15(11):7270-7281.
2. Andreasen N.C., Rezai K., Alliger R., Swayze V.W., Flaum M., Kirchner P., Cohen G., O'Leary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the tower of London. Arch Gen Psychiatry 1992, 49(12):943-958.
3. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald A.W., Noll D.C., Cohen J.D. Selective deficits in prefrontal cortex function in medication naive patients and schizophrenia. Arch Gen Psychiatry 2001, 58:280-288.
4. Baruch I., Hemsley D.R., Gray J.A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Ner Men Dis 1988, 176:598-606.
5. Birrell J.M., Brown V.J. Medial frontal cortex mediates attentional set-shifting in the rat. J Neuorsci 2000, 20(11):4320-4324.
6. Bussey T.J., Muir J.L., Everitt B.J., Robbins T.W. Triple dissociation of anterior cingulated, posterior cingulated, and medial frontal cortices on visual discrimination tasks using a touchscreen testing procedure for the rat. Behav Neurosci 1997, 111(5):920-936.
7. Coutureau E., Galani R., Gosselin O., Majchrzak M., Di Scala G. Entorhinal but not hippocampal or subicular lesions disrupt latent inhibition in rats. Neurobiol Learn Mem 1999, 72(3):143-157.
8. de Bruin J.P., Sànchez-Santed F., Heinsbroek R.P., Donker A., Postmes P. A behavioural analysis of rats with damage to the medial prefrontal cortex using the Morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigation. Brain Res 1994, 652:323-333.
9. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 1990, 521(1-2):311-315.
10. Eisenberg D.P., Berman K.F. Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neurospsychopharmacology 2010, 35(1):258-277.
11. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 1996, 75(2):535-542.
12. Gal G., Schiller D., Weiner I. Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: the neural site controlling the expression and disruption of the stimulus preexposure effect. Behav Brain Res 2005, 162:246-255.
13. Gal G., Barnea Y., Biran L., Mendlovic S., Gedi T., Halavy M., Feldon J., Fennig S., Levkovitz Y. Enhancement of latent inhibition in patients with chronic schizophrenia. Behav Brain Res 2009, 197(1):1-8.
14. Geyer M.A., Moghaddam B. Animal models relevant to schizophrenia disorders. Neuropsychopharmacology: the fifth generation of progress 2002, Lippincott Williams & Wilkins, Philadelphia. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
15. Goodman J.M., Seidman L.J., Patti M., Strous R.D., Strauss M., Caplan B., Patel J.K., Zimmet S., Jenkin B., Green A.I. A functional MRI study of working memory in first-episode schizophrenic patients. Schizophr Res 1999, 36:221-222.
16. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., Smith A.D. The neuropsychology of schizophrenia. Behav Brain Sci 1991, 14:1-20.
17. Gray N.S., Pickering A.D., Hemsley D.R., Dawling S., Gray J.A. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology 1992, 107:425-430.
18. Heidbreder C.A., Groenewegen H.J. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 2003, 27(6):555-579.
19. Honey R.C., Good M. Hippocampal lesions abolish the contextual specificity of latent inhibition and conditioning. Behav Neurosci 1993, 107(1):23-33.
20. Joel D., Weiner I., Feldon J. Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin card sorting test, but do not disrupt latent inhibition: implications for animal models of schizophrenia. Behav Brain Res 1997, 85(2):187-201.
21. Joseph M.H., Peters S.L., Moran P.M., Grigoryan G.A., Young A.M.J., Gray J.A. Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience 2000, 101:921-930.
22. Kehagia A.A., Murray G.K., Robbins T.W. Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 2010, 20:199-204.
23. Killcross S., Coutureau E. Coordination of actions and habits in the medial prefrontal cortex of rats. Cereb Cortex 2003, 13(4):400-408.
24. Kumari V., Cotter P.A., Mulligan O.F., Checkley S.A., Gray N.S., Hemsley D.R., Thornton J.C., Corr P.J., Toone B.K., Gray J.A. Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers. J Psychopharmacol 1999, 13:398-405.
25. Lacroix L., Broersen L.M., Weiner I., Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 1998, 84(2):431-442.
26. Lacroix L., Broersen L.M., Weiner I., Feldon J. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res 2000, 107(1-2):111-121.
27. Lacroix L., Spinelli S., White W., Feldon J. The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience 2000, 97(3):459-468.
28. Lipska B.K., Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000, 23(3):223-239.
29. Lubow R.E., Moore A.U. Latent inhibition: the effect of non-reinforced preexposure to the conditional stimulus. J Comp Physiol Psychol 1959, 52:415-419.
30. Lubow R.E., Weiner I. Issues in latent inhibition research and theory: an overview. Latent inhibition: cognition, neuroscience and applications to schizophrenia 2010, 531-557. Cambridge University Press, Cambridge. R.E. Lubow, I. Weiner (Eds.).
31. MacDonald A.W., Carter C.S., Kerns J.G., Ursu S., Barch D.M., Holmes A.J., Stenger V.A., Cohen J.D. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry 2005, 162:475-484.
32. McGaughy J., Ross R.S., Eichenbaum H. Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 2008, 153(1):63-71.
33. Naneix F., Marchand A.R., Di Scala G., Pape J.R., Coutureau E. A role for medial prefrontal dopaminergic innervation in instrumental conditioning. J Neurosci 2009, 29(20):6599-6606.
34. Pan W.H., Yang S.Y., Lin S.K. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 2004, 53(1):44-52.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Academic Press, San Diego, CA. (5th ed).
36. Peleg-Raibstein D., Pezze M.A., Ferger B., Zhang W.N., Murphy C.A., Feldon J., Bast T. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats. Neuroscience 2004, 132(1):219-232.
37. Ragozzino M.E., Dertick S., Kesner R.P. Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J Neurosci 1999, 19(11):4585-4594.
38. 1 receptor blockade in the prelimbic-infralimbic areas on behavioural flexibility. Learn Mem 2002, 9:18-28.
39. Ragozzino M.E. The contribution of the medial prefrontal cortex, oribiotofrontal cortex, and dorsomedial striatum to behaviourally flexibility. Ann N Y Acad Sci 2007, 1121:355-375.
40. Robbins T.W., Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 2007, 17(Suppl 1):151-161.
41. Rosin D.L., Clark W.A., Goldstein M., Roth R.H., Deutch A.Y. Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience 1992, 48(4):831-839.
42. Schiller D., Weiner I. Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition. Neuroscience 2004, 128(1):215-222.
43. Schiller D., Weiner I. Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift. Behav Brain Res 2005, 163(1):115-121.
44. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 1989, 290(2):213-242.
45. Shadach E., Gaisler I., Schiller D., Weiner I. The latent inhibition model dissociates between clozapine, haloperidol and ritanserin. Neuropsychopharmacology 2000, 23:151-161.
46. Solomon P.R., Crider A., Winkelman J.W., Turi A., Kamer R.M., Kaplan L.J. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 1981, 16:519-537.
47. Tai C.-T., Cassaday H.J., Feldon J., Rawlins J.N.P. Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiol Learn Mem 1995, 64:36-48.
48. Takagishi M., Chiba T. Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study. Brain Res 1991, 566(1-2):26-39.
49. van der Meulen J.A., Joosten R.N., de Bruin J.P., Feenstra M.G. Dopamine and noradrenalin efflux in the medial prefrontal cortex during serial reversals and extinction of instrumental goal-directed behaviour. Cereb Cortex 2007, 17(6):1444-1453.
50. Weiner I., Lubow R.E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 1984, 83:194-199.
51. Weiner I., Feldon J. Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology 1987, 91:248-253.
52. Weiner I. Neural substrates of latent inhibition: the switching model. Psychol Bull 1990, 108:442-461.
53. Weiner I. The "two-headed" latent inhibition model of schizophrenia: modelling positive and negative symptoms and their treatment. Psychopharmacology 2003, 169:257-297.
54. Weiner I., Arad M. Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment. Behav Brain Res 2009, 204:369-386.
55. Williams H., Wellman H.E., Geaney D., Feldon J., Cowen P., Rawlins J.N.P. Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology 1997, 133:262-268.